ASND 241115 125.00C (ASND241115C125000) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

ASND241115C125000

Watchlist

9.50
+2.50+35.71%

15min DelayClose Oct 18 16:00 ET

9.50High9.00Low

Intraday

5D
Daily

News

European Equities Traded in the US as American Depositary Receipts Move Slightly Higher in Thursday Trading
MT NewswiresOct 17 11:13 ET
Ascendis Pharma Ticks Higher Amid Report It Cancelled From Upcoming Conference
Seeking AlphaOct 16 12:11 ET
MBX Bio Drops Despite Bullish Views on Street
Seeking AlphaOct 8 15:15 ET
Septerna, Hypoparathyroidism Drug Developer, Files for $100M IPO
Seeking AlphaOct 3 13:36 ET
Ascendis Pharma Submits Supplemental Biologics License Application for Pediatric Growth Hormone Drug
MT NewswiresSep 30 09:23 ET
Express News | Ascendis Pharma Presents 3-Year Data At ASBMR 2024 Showing Long-Term Treatment With TransCon PTH Normalizes Bone Remodeling In Adults With Hypoparathyroidism
BenzingaSep 30 08:33 ET

Comments

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$

1

$Ascendis Pharma A/S (ASND.US)$ big rebound from drop after financials , from 111 to 150. that's a good profit for those who payed attention. $NVIDIA (NVDA.US)$ $Apple (AAPL.US)$

1

$Ascendis Pharma A/S (ASND.US)$ reporting wasn't so terrible that it deserves a15% drop. could see this rebounding above the price before the drop

1

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Nice curl! On watch for recovery. May swing.

$Ascendis Pharma A/S (ASND.US)$

1

Read more